On the other hand, mutated DOT1L mimicking constitutive acetylation (K358Q) can rescue the growth deficiency of MLLr leukaemia cells with ATM loss, which validates our speculation that DOT1L serves as a downstream target of ATM. This evidence concerns the gene ATM and leukemia.